These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 16127626)
1. Topoisomerase inhibitors and other new agents. McKinnon C IDrugs; 1999 Jul; 2(7):629-32. PubMed ID: 16127626 [TBL] [Abstract][Full Text] [Related]
2. New agents for colon and breast cancer. McKinnon C IDrugs; 1998 Jun; 1(2):168-71. PubMed ID: 18465523 [TBL] [Abstract][Full Text] [Related]
3. [Frontier of mycobacterium research--host vs. mycobacterium]. Okada M; Shirakawa T Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793 [TBL] [Abstract][Full Text] [Related]
4. [The hospital of the "Vrije Universiteit" in Amsterdam]. Spoelstra-Dekker BC Tijdschr Ziekenverpl; 1966 Nov; 19(21):708-9. PubMed ID: 5179951 [No Abstract] [Full Text] [Related]
5. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
6. The cancer and leukemia group B pharmacology and experimental therapeutics committee: a historical perspective. Ratain MJ; Miller AA; McLeod HL; Venook AP; Egorin MJ; Schilsky RL Clin Cancer Res; 2006 Jun; 12(11 Pt 2):3612s-6s. PubMed ID: 16740794 [TBL] [Abstract][Full Text] [Related]
7. [At the death of Dr. Jan Waterink, Professor in psychology and pedagogics at the Vrije Universiteit from 1926-1961]. Fokkema SD Ned Tijdschr Psychol; 1967 Jan; 22(1):1-6. PubMed ID: 5343015 [No Abstract] [Full Text] [Related]
8. The TheoCheM Group at the Vrije Universiteit. Angew Chem Int Ed Engl; 2023 Jun; 62(25):e202302661. PubMed ID: 37143129 [TBL] [Abstract][Full Text] [Related]
10. Oral malignant melanoma: the amsterdam experience. Meleti M; Leemans CR; Mooi WJ; van der Waal I J Oral Maxillofac Surg; 2007 Nov; 65(11):2181-6. PubMed ID: 17954312 [TBL] [Abstract][Full Text] [Related]
11. Synergistic interaction between histone deacetylase and topoisomerase II inhibitors is mediated through topoisomerase IIbeta. Marchion DC; Bicaku E; Turner JG; Daud AI; Sullivan DM; Munster PN Clin Cancer Res; 2005 Dec; 11(23):8467-75. PubMed ID: 16322310 [TBL] [Abstract][Full Text] [Related]
12. The new set-up of the medical informatics Master of Science program at the University of Amsterdam. Jaspers MW; Hasman A Int J Med Inform; 2007 Dec; 76 Suppl 3():S369-76. PubMed ID: 17499545 [TBL] [Abstract][Full Text] [Related]
13. In vitro assessment of novel transcription inhibitors and topoisomerase poisons in rhabdomyosarcoma cell lines. Wolf SJ; Wakelin LP; He Z; Stewart BW; Catchpoole DR Cancer Chemother Pharmacol; 2009 Nov; 64(6):1059-69. PubMed ID: 19277661 [TBL] [Abstract][Full Text] [Related]
14. A three-dimensional quantitative structure-activity analysis of a new class of bisphenol topoisomerase IIalpha inhibitors. Liang H; Wu X; Yalowich JC; Hasinoff BB Mol Pharmacol; 2008 Mar; 73(3):686-96. PubMed ID: 18045852 [TBL] [Abstract][Full Text] [Related]
15. Novel tetra-acridine derivatives as dual inhibitors of topoisomerase II and the human proteasome. Vispé S; Vandenberghe I; Robin M; Annereau JP; Créancier L; Pique V; Galy JP; Kruczynski A; Barret JM; Bailly C Biochem Pharmacol; 2007 Jun; 73(12):1863-72. PubMed ID: 17391647 [TBL] [Abstract][Full Text] [Related]
16. NK314, a novel topoisomerase II inhibitor, induces rapid DNA double-strand breaks and exhibits superior antitumor effects against tumors resistant to other topoisomerase II inhibitors. Onda T; Toyoda E; Miyazaki O; Seno C; Kagaya S; Okamoto K; Nishikawa K Cancer Lett; 2008 Jan; 259(1):99-110. PubMed ID: 17998154 [TBL] [Abstract][Full Text] [Related]
17. Kidney transplantation at the University of Illinois at Chicago from 1988-2004. Oberholzer J; Testa G; Sankary H; John E; Thielke J; Benedetti E Clin Transpl; 2004; ():143-9. PubMed ID: 16704147 [TBL] [Abstract][Full Text] [Related]
18. The redesign of the Medical Informatics Master of Science course at the University of Amsterdam. Jaspers MW; Hasman A Stud Health Technol Inform; 2006; 124():873-8. PubMed ID: 17108622 [TBL] [Abstract][Full Text] [Related]
19. Novel dual-targeting benzimidazole urea inhibitors of DNA gyrase and topoisomerase IV possessing potent antibacterial activity: intelligent design and evolution through the judicious use of structure-guided design and structure-activity relationships. Charifson PS; Grillot AL; Grossman TH; Parsons JD; Badia M; Bellon S; Deininger DD; Drumm JE; Gross CH; LeTiran A; Liao Y; Mani N; Nicolau DP; Perola E; Ronkin S; Shannon D; Swenson LL; Tang Q; Tessier PR; Tian SK; Trudeau M; Wang T; Wei Y; Zhang H; Stamos D J Med Chem; 2008 Sep; 51(17):5243-63. PubMed ID: 18690678 [TBL] [Abstract][Full Text] [Related]
20. Conjugation of human topoisomerase 2 alpha with small ubiquitin-like modifiers 2/3 in response to topoisomerase inhibitors: cell cycle stage and chromosome domain specificity. Agostinho M; Santos V; Ferreira F; Costa R; Cardoso J; Pinheiro I; Rino J; Jaffray E; Hay RT; Ferreira J Cancer Res; 2008 Apr; 68(7):2409-18. PubMed ID: 18381449 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]